Tipsheet
What matters at India’s listed companies
Order Wins · Pharmaceuticals · Micro cap

Veerhealth lands ₹3.6 cr face-care order from undisclosed FMCG client

The contract is worth 11% of the nano-cap's annual revenue and must ship within 45 days.

2 earlier stories on Veerhealth Care Ltd.
Mkt cap₹49 cr
P/E89.91×
ROE1.76%
Debt / eq.0.22
₹3.6 cr Value of the new face-care supply order.

What's new

  • Veerhealth Care won a ₹3.6 crore order from an unnamed Indian FMCG company for face care products.
  • Execution is locked in within 45 days.
  • The deal follows a string of recent wins, including a ₹6.16 crore domestic contract, that lifted annual revenue to ₹32.5 crore in FY26.

Why this matters

For a ₹48 crore market-cap company, a single order of this size is 11% of last year's revenue and 7.5% of the equity value. It's a big chunk of near-term sales packed into a 45-day window. The unnamed FMCG counterparty suggests the client wants discretion, which often means a large brand testing a new contract manufacturer.

What we're watching

  • Whether the FY27 revenue run-rate sustains the ₹32.5 cr trajectory from FY26.
  • If Veerhealth can name the FMCG client once the contract matures.
  • Gross-margin impact from a large, short-timeline order.

The full read

Veerhealth Care has won a ₹3.6 crore order from an unnamed Indian FMCG company for face care products, to be executed within 45 days. For a contract manufacturer with a ₹48 crore market cap and ₹32.5 crore in FY26 revenue, that single order represents 11% of annual sales and 7.5% of equity value. The deal adds to a recent string of wins, including a ₹6.16 crore domestic contract, that have stretched Veerhealth's order book. The client's identity is locked behind a confidentiality clause, a common move when a large brand is piloting a new manufacturing partner. The revenue is booked fast. The test is whether Veerhealth can keep filling the pipeline at this pace.

Questions answered

Why is a ₹3.6 crore order material for Veerhealth?
The company had annual revenue of ₹32.5 crore in FY26 and a market capitalisation of ₹48 crore. This single order equals 11% of revenue and 7.5% of market value, making it a significant portion of both.
Who is the client?
An undisclosed Indian FMCG company. Veerhealth withheld the identity under confidentiality terms.
How quickly must this be delivered?
Within 45 days of the order, creating a tight execution window for the contract manufacturer.
Is this order part of a broader trend for the company?
Yes. Veerhealth has won several domestic and export orders over the past year, including a ₹6.16 crore domestic deal, which together drove its annual revenue to ₹32.5 crore in FY26.
Mentioned: ₹3.6 cr order · Undisclosed Indian FMCG company · FY26 revenue ₹32.5 cr
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

  1. 9 Jun 2026 · 4:08 PM IST Veerhealth lands ₹3.6 cr face-care order from undisclosed FMCG client
  2. 10d ago Veerhealth Care revenue nearly doubles to ₹32.5 cr, but Q4 slips to a loss
  3. 15d ago Veerhealth Care's board meets to approve FY26 results and weigh a dividend